February 11, 2020
California State Capitol
Sacramento, CA 95814
The goal of this briefing is (1) to educate policymakers and the general public about the importance of biomarker testing in helping patients access the latest and highest-quality precision medicine treatments, (2) to discuss recent advancements in precision medicine in cancer, and (3) to share success stories/patient examples of benefits of timely and accurate biomarker testing and precision medicine access.
The briefing will cover precision medicine across multiple cancer types.
The event is free but registration is required. Lunch will be provided.